UBE2A and Alzheimer disease: This in turn was suggested to trigger downregulation of microRNA-7-regulated genes associated with the AD, for example ubiquitin protein ligase A (UBE2A), an important AD therapeutic target, functionally involved in clearing toxic amyloid peptides from the patients’ brain [15].